BFM
RVPH

Boothbay Fund Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Boothbay Fund Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,435
Closed -$19.2K – 2427
2025
Q4 		$19.2K Buy
+3,435
New +$38.2K ﹤0.01% 1887
2023
Q4 		– Sell
-5,485
Closed -$535K – 1940
2023
Q3 		$535K Buy
+5,485
New +$511K 0.01% 1002

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Boothbay Fund Management's RVPH Position: Q1 2020 in Review

Boothbay Fund Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2020, closing a stake of 13,004 shares — an estimated $2.71M sold.

Boothbay Fund Management first reported a position in RVPH in Q2 2019 and held it in 3 quarters. The position peaked at $2.71M in Q4 2019. 24 funds tracked by Wall St. Rank hold RVPH as of Q1 2020.

  • Boothbay Fund Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 13,004 REVIVA PHARMA HLDGS INC shares in Q1 2020, an estimated $2.71M.
  • Boothbay Fund Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2019 and held it in 3 quarters.
  • Boothbay Fund Management's REVIVA PHARMA HLDGS INC position peaked at $2.71M in Q4 2019.
  • 24 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.